COMIRNATY
Google image searchProduct monograph
Active ingredient
*sarscov2 s-protein mrna, 5'[m27,3'-ogppp(m12'-o)apg], 3'polya+linker, 10 MCG/0.3 ML
DIN: 02541858
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Description: SINGLE DOSE VIAL AND MULTIDOSE VIAL
Schedule: Schedule D
Company: BIONTECH MANUFACTURING GMBH
Date: 24-SEP-2024
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BN — Covid-19 vaccines (ATC, ATC/DDD)
- J07BN01 — COVID-19, RNA-BASED VACCINE (ATC/DDD)
Reference brand drug: Comirnaty, Spikevax